Biography
Dr. J. Mark FitzGerald is the co-director of the Centre for Lung Health. He previously was head of the Respiratory Medicine Divisions at both the University of British Columbia (UBC) and Vancouver General Hospital. He is past chair of the GINA Science Committee and Chair of the GINA Executive and continues to be a member of both. He is also past president of the Canadian Thoracic Society.
Dr. FitzGerald graduated from University College Dublin in 1978. After interning and training in internal medicine in Dublin, he worked for two years in Lesotho as a general internist. Subsequently, he completed post-graduate training in respiratory medicine and clinical epidemiology at McMaster University before accepting a position on faculty at McMaster University in 1987. He moved to UBC in 1989 and is currently a professor of respiratory medicine at UBC.
Dr. FitzGerald's clinical and research interests include asthma, chronic obstructive lung disease and health outcomes. His current research focuses on health literacy and ethnicity in the management of asthma and COPD as well as the economic evaluation of asthma and its cost effective treatment. He has been involved in a number of regional and provincial initiatives to improve COPD care. As a principal investigator with the NCE AllerGen, he is involved in the evaluation of novel new asthma therapies. More recently he has been co-principal investigator on a series of studies which have demonstrated a novel new strategy for the treatment of mild asthma. He has also been extensively involved in the evaluation of novel new therapies for severe asthma. As a principal investigator with the NCE AllerGen, he is involved in the evaluation of novel new asthma therapies. He has published over 600 peer reviewed papers and editorials in high impact journals, including the New England Journal of Medicine, British Medical Journal, The Lancet, Annals of Internal Medicine and the Journal of the American Medical Association.
Research Studies
Canadian Asthma Text Messaging Study
Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps
Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma
An Open-Label Compassionate Use and Long-Term Access Study of Mepolizumab in HES
News and Awards


Publications
- BMC medical research methodology -
- Lancet (London, England) -
- The New England journal of medicine -
- The Lancet. Respiratory medicine -
- The Lancet. Respiratory medicine -